About Us
SL BIO Co., Ltd. (SL BIO) focuses on developing cell and gene translation technologies to enhance the clinical effectiveness of innovative cell therapies. The company is actively advancing platforms in immune based therapies, with a strong emphasis on oncology and exosome research. With applications in cancer and regenerative health, SL BIO holds strong future potential. From 2023 to 2024, as part of its strategic growth plan, SL BIO completed a capital increase in June 2024 and reorganized its investment structure on June 14, 2024.
Gamma Delta T
At SL BIO, we are proud to bring groundbreaking advancements in immunotherapy to the forefront through our collaboration with JY Biomedical and their licensed Gamma Delta T cell platform. This innovative approach harnesses the distinct biology of Gamma Delta T cells to deliver targeted and effective immunotherapeutic solutions for cancer treatment.
JY Biomedical’s Gamma Delta T cell technology reflects leading-edge research and adherence to high regulatory standards. Registered under the U.S. FDA Drug Master File (DMF #041080), the platform supports stringent expectations for clinical quality, safety, and performance. SL BIO builds upon this strong foundation to help make transformative cell based therapies more accessible to patients worldwide.
We remain committed to pushing the boundaries of immunotherapy by combining advanced science, deep expertise, and a shared goal of improving health outcomes globally.
Armed-Gamma Delta T
SL BIO is advancing cancer immunotherapy by integrating gamma-delta (γδ) T cells with precision-guided bispecific antibodies to develop its Armed-GDT platform. This next generation approach builds upon the therapeutic cytotoxic properties of γδ T cells, enabling more accurate recognition and destruction of tumor cells. By enhancing both the specificity and functional activity of these immune cells, Armed-GDT offers a powerful and adaptable strategy for tackling difficult to treat cancers.
Milk-derived Exosomes
Milk-derived Exosomes are nanosized extracellular vesicles naturally secreted from milk, rich in bioactive molecules such as proteins, lipids, and RNA. These vesicles facilitate intercellular communication and are recognized for their roles in promoting tissue repair, modulating immune responses, and reducing inflammation. Derived from bovine or other animal milk sources, Milk Exosomes offer a safe, biocompatible, and cell-free alternative for topical applications, especially in cosmetic and dermatological formulations.
Tangerine-derived Extract
Citrus reticulata (Tangerine) Extract is a plant-based botanical derived from nutrient-rich tangerines, renowned for its high content of natural antioxidants, flavonoids, and anti-inflammatory compounds. Extracted through a gentle, solvent-free process, this extract preserves the integrity of its bioactive components, including plant-derived polyphenols, essential oils, and trace vitamins. Known for its purifying and revitalizing properties, it helps balance sebum production, soothe irritated skin, and support the scalp’s natural renewal process. Its lightweight, non-irritating nature makes it ideal for oily or combination skin, as well as sensitive scalps prone to buildup or inflammation. Sustainable and multifunctional, Citrus reticulata extract offers a modern, natural approach to maintaining skin and scalp health in today’s urban environments.
News
